Pantai Hospital Kuala Lumpur Advances Adult Congenital Heart Care with First Minimally Invasive PDA Device Closure
KUALA LUMPUR, Malaysia, June 6, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) marked a significant milestone in cardiovascular care with the successful transcatheter device occlusion of a patent ductus arteriosus (PDA) in an adult patient with congenital heart disease — a first for the hospital's Interventional Cardiology Laboratory (ICL).
The patient, who was initially referred for open-heart surgery involving PDA ligation and ventricular septal defect (VSD) closure, was carefully evaluated by PHKL's multidisciplinary cardiac team. A detailed transoesophageal echocardiogram (TOE) revealed a single tiny VSD that did not require immediate surgical repair, allowing the team to opt for a less invasive, catheter-based approach.
"This case is a testament to multidisciplinary, patient-centred approach," said Dr Siti Laura, Consultant Paediatric Cardiothoracic Surgeon at PHKL. "By opting for a minimally invasive PDA device occlusion, we were able to offer the patient a faster recovery, smaller incision, and significantly reduced scarring."
This successful procedure highlights PHKL's expanding capabilities in adult congenital heart care, a specialised and growing field that requires collaborative planning and tailored interventions. It also reflects the hospital's commitment to delivering innovative, minimally invasive solutions for structural heart conditions in adults — a group often underrepresented in congenital cardiac care
Our ability to perform such procedures reflects the hospital's continuous investment in advanced cardiac technology and our commitment to improving outcomes for patients with congenital heart disease," Dr Siti Laura added. "We will continue to monitor the patient's condition closely — particularly her VSD — to ensure optimal long-term care.
PHKL reinforces its position as a tertiary referral centre and a growing centre of excellence for adult congenital heart disease management in Malaysia. For more information about Paediatric and Congenital Cardiothoracic Services at PHKL, please visit: https://www.pantai.com.my/kuala-lumpur/congenital-cardiothoracic.
-END-
***
Dr Siti Laura Mazalan, Consultant Paediatric and Congenital Cardiothoracic Surgeon
MBBS (University of Malaya, Malaysia), MMed Surg (University Kebangsaan Malaysia, Malaysia), Fellowship in Paediatric Cardiac Surgery (Birmingham Children Hospital, United Kingdom)
Dr. Siti Laura is a highly accomplished Paediatric Cardiothoracic Surgeon deeply committed to serving vulnerable in Malaysia. Her medical journey commenced with an MBBS from the University of Malaya in 1998, followed by a Master of Medicine (Surgery) from Universiti Kebangsaan Malaysia in 2004. Beginning her career at Institute Jantung Negara in 2004, she devoted 14 years to the institution as a Consultant Cardiothoracic Surgeon. Motivated by her dedication to enhancing healthcare, she pursued a transformative one-year Fellowship in Paediatric Cardiac Surgery at Birmingham Children's Hospital in 2010.
In 2020, Dr. Siti Laura joined Serdang Hospital, where she played a pivotal role in establishing the Paediatric Cardiothoracic service, catering to underprivileged children with congenital heart diseases in the nation. She subsequently became a Consultant Paediatric Cardiothoracic Surgeon at Pantai Hospital Kuala Lumpur. Dr Siti Laura's area of interest includes Neonatal and Paediatric Cardiothoracic Surgery, Adult Congenital Cardiac Surgery, Single Ventricle Heart Surgery, ECMO support (Extracorporeal membrane oxygenation), Slide Tracheoplasty Surgery in neonates and paediatric patients and Cardiac Homograft Banking. Dr Siti Laura's expertise and unwavering dedication continue to make a profound impact on the lives of her patients and the healthcare community.
***
About Pantai Hospital Kuala Lumpur
For five decades, Pantai Hospital Kuala Lumpur has been the heartbeat of Kuala Lumpur, steadfastly delivering exceptional care to patients from all walks of life. Since its inception in 1974 with just 68 beds and 20 medical specialists, the hospital has grown into a healthcare icon today with 507 beds, over 200 consultants and counting. Our pursuit of quality healthcare, clinical excellence, and cutting-edge technology is underscored by our service quality and dedication towards clinical research.
This has earned us accreditations from the Malaysian Society for Quality in Health (MSQH) and the Joint Commission International (JCI). Additionally, we hold certification as a Baby-Friendly Hospital and is a preferred hospital in Malaysia by the World Health Organization (WHO). As we celebrate our 50th anniversary, Pantai Hospital Kuala Lumpur looks to the future, unwaveringly committed to continuing its legacy of excellence with world-class healthcare services and innovative treatments for generations to come. Learn more at www.pantai.com.my/kuala-lumpur.
For more information, please contact:Callie Phin, Pantai Hospital Kuala LumpurEmail: callie.phin@pantai.com.my Tel No.: 014-686 7066
For media enquiry:Natasha Loo, PR Lab ConsultancyEmail: tasha@pr-lab.co Tel No.: 010-231 0110
Lim Joe Ee, PR Lab ConsultancyEmail: joe.lim@pr-lab.co Tel No.: 012-635 9839
Ally Chai, PR Lab ConsultancyEmail: ally@pr-lab.co Tel No.: 016-232 7625
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/pantai-hospital-kuala-lumpur-advances-adult-congenital-heart-care-with-first-minimally-invasive-pda-device-closure-302474408.html
SOURCE Pantai Hospital Kuala Lumpur
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
AOFAS Awards More Than $258,000 in Grants to Fund Foot and Ankle Orthopaedic Research
SCHAUMBURG, Ill., June 6, 2025 /PRNewswire/ -- The American Orthopaedic Foot & Ankle Society (AOFAS) awarded its annual research grants to 12 promising foot and ankle research projects. With funding from the Orthopaedic Foot & Ankle Foundation, the AOFAS Research Grants Program provides AOFAS members and their research teams with the resources to discover new foot and ankle treatments and advance patient care. This year, the AOFAS continued its commitment to research by awarding more than $258,000 in funding—including two Resident Awards that support the work of an orthopaedic resident, and two Early Career Awards that recognize a researcher less than 10 years out of fellowship. First-time research grant applicants were also awarded 10 percent advantage in overall score. "The AOFAS Research Grants Program supports innovative studies and provides opportunities for our surgeons—especially those early in their careers—to contribute to the future of our specialty," said AOFAS Research Committee Chair Michael C. Aynardi, MD, from Penn State Health Milton S. Hershey Medical Center in Pennsylvania. In addition to the Resident and Early Career Awards, the AOFAS awarded two Established Project Grants (up to $50,000), five Small Project Grants (up to $20,000 each), and the Ronald and Wendy Smith Clinical Research Grant (up to $25,000). Established in 2021 with a generous donation from AOFAS Past President Ronald W. Smith, MD, and his wife, Wendy, the Ronald and Wendy Smith Clinical Research Grant funds promising prospective research studies in areas of high clinical importance. Since 1997, AOFAS has awarded more than $2.5 million in research grants. The AOFAS Research Grants Program is funded by the Orthopaedic Foot & Ankle Foundation, supported in part by a grant from Arthrex, Inc. "By advancing research, we are equipping physicians with the knowledge to better diagnose and treat complex foot and ankle condition, ultimately improving patient care," Dr. Aynardi said. Congratulations to the 2025 AOFAS Research Grant Recipients! Established Project Grants (up to $50,000) Validation of Novel Biomarkers to Differentiate Foot and Ankle Infections from Inflammatory Arthritis Irvin Oh, MD Lower Extremity Gait, Mobility, and Balance Confidence in Charcot-Marie-Tooth Patients with Cavovarus Foot Deformity Bopha Chrea, MD Small Project Grants (up to $20,000) The Efficacy of TMR in Diabetic Neuroma Pain Reduction Edward Lee, MD, MS Nonpsychotrophic Cannabinoids May Enhance Fracture Healing in a Murine Neuropathic Model Ashlee MacDonald, MD Biological and Histological Analysis of Zadek Calcaneal Osteotomy vs. Open Achilles Tendon Splitting Procedure for Insertional Achilles Tendinosis Tyler Gonzalez, MD, MBA Adenosine Therapy to Treat Charcot Arthropathy Samuel Adams, MD Neuromuscular Electrical Stimulation in Foot and Ankle Surgery: A Randomized Controlled Trial Raymond J. Walls, MD Early Career Awards (up to $20,000) The Passive Collection of Wearable Data and Self-Reported Outcomes in Orthopaedic Foot and Ankle Patients David Jaffe, MD Long-Term Outcomes following Reconstruction of the Flexible Progressive Collapsing Foot Deformity Matthew Conti, MD Resident Awards (up to $5,000) A Not-So-Silent Threat: The Impact of Surgical Suction Devices on Noise in the Foot and Ankle Operating Room Daniel Santana, MD, MS Mentor: Eric Giza, MD Contact Pressures During Lower Extremity Immobilization: A Biomechanical Study Erik Nakken, MD Mentor: James Holmes, MD Ronald and Wendy Smith Clinical Research Grant (up to $25,000) Development of a Limb Risk Assessment Model for Patients with Diabetic Foot Syndrome Christopher Gross, MD; Daniel Scott, MD, MBA About Foot and Ankle Orthopaedic Surgeons Foot and ankle orthopaedic surgeons are medical doctors (MD and DO) who specialize in the diagnosis and treatment of musculoskeletal disorders and injuries of the foot and ankle. Their education and training consist of four years of medical school, five years of postgraduate residency, and a fellowship year of specialized surgical training. These specialists care for patients of all ages, performing reconstructive surgery for deformities and arthritis, treating sports injuries, and managing foot and ankle trauma. About the AOFAS The American Orthopaedic Foot & Ankle Society (AOFAS) mobilizes our dynamic community of foot and ankle orthopaedic surgeons to improve patient care through education, research, and advocacy. As the premier global organization for foot and ankle care, AOFAS delivers exceptional events and resources for continuous education, funds and promotes innovative research, and broadens patient understanding of foot and ankle conditions and treatments. By emphasizing collaboration and excellence, AOFAS inspires ever-increasing levels of professional performance leading to improved patient outcomes. For more information, visit View original content to download multimedia: SOURCE American Orthopaedic Foot & Ankle Society Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Nuvia's Chief Clinical Officer, Dr. Preston Hansen, Featured as May Cover Story in CXO Magazine
SALT LAKE CITY, June 6, 2025 /PRNewswire/ -- Nuvia Dental Implant Center's Chief Clinical Officer, Dr. Preston Hansen, has been featured as the May 2025 cover story of CXO Magazine—a global leadership magazine spotlighting industry changemakers. In the article titled "Transforming Healthcare Through Life-Changing Patient Experiences," Dr. Hansen shares his journey from a young dental student to now leading a monumental change in the dental implant industry with a new approach to full mouth restorations. The feature highlights just how groundbreaking Nuvia's process is. The ability to deliver permanent full-mouth dental implants just 24 hours after surgery is disrupting traditional care methods that have hardly been innovated for decades. With a new approach, Nuvia is restoring smiles, changing lives, and re-imagining the patient experience. In the Feature CXO covers Dr. Hansen's surgical background, his passion for patient care, and Nuvia's commitment to giving patients the smiles they've always wanted in a timeframe that not only promotes healing, but is extremely convenient for patients. Dr. Hansen shares about what treatment is like saying, "We built everything around one promise: give people back their smiles and their lives in a way that's fast, safe, and predictable". With a team of oral surgeons, restorative dentists, CRNAs, and in-house lab technicians, Nuvia has created a rare dental implant experience that prioritizes safety and comfort so patients never have to question if they're in good hands. The feature also distinguishes between the old and new method of approaching dental implants, emphasizing that Nuvia patients aren't given a temporary set of teeth after their dental implants are placed. The CXO feature also highlights Nuvia's recent national recognitions, including: "Dental Restoration Company of the Year" — Awarded by Healthcare Business Review for both 2024 and 2025 99.13% implant success rate Thousands of lives transformed through a 24-hour permanent smile process "Traditional treatment plans can take months or even years" Dr. Hansen says in the article. "Our approach delivers a permanent solution in 24 hours—with fewer appointments, less downtime, and far more predictability." To see first hand stories from Nuvia patients, check out Nuvia TV. About Nuvia Dental Implant Center Nuvia exclusively does full-mouth dental implants delivered with permanent teeth in just 24 hours—not temporary dentures. With a highly coordinated team approach, advanced imaging, and an in-house lab, Nuvia provides a safe, fast, and predictable alternative to traditional implant methods. With multiple U.S. locations and thousands of life-changing procedures completed each year, Nuvia is offering a proven, one and done treatment for those with missing or failing teeth. Media Contact: marketing@ View original content to download multimedia: SOURCE Nuvia Dental Implant Center Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
2 hours ago
- Yahoo
Pepin Heart Institute at AdventHealth Tampa becomes first in Tampa Bay to complete 1,000th WATCHMAN™ heart procedure
TAMPA, Fla., June 5, 2025 /PRNewswire/ -- The heart care experts at the Pepin Heart Institute, a part of AdventHealth Tampa, are now the first in the Tampa Bay area to complete 1,000 WATCHMAN ™ procedures, a minimally-invasive surgery that helps prevent stroke and cardiovascular death in patients with atrial fibrillation (AFib) who are at increased risk. The WATCHMAN is a device about the size of a quarter. It's implanted via catheter through a vein in the upper leg and placed in the heart's left atrial appendage, where more than 90 percent of stroke-causing clots originate in patients with non-valvular AFib. Once in place, the device creates a long-term solution for stroke prevention. "Hitting this milestone, with the 1,000th WATCHMAN procedure recently completed by Dr. Paul Gerczuk, reflects our commitment to delivering leading-edge cardiovascular care using the most advanced techniques available," said Dr. Kenneth Yamamura, a board-certified electrophysiologist at the Pepin Heart Institute. "The WATCHMAN allows us to reduce our patients' stroke risk and help them come off blood thinners over time, significantly improving their quality of life." For Gregory Kingery of Sebring, the procedure was life changing. After being diagnosed with AFib, Kingery struggled to breathe and walk. Today, he credits the WATCHMAN with giving him his life back. "There's a lot of people who don't get a second lease on life," Kingery said. "I'm grateful I did." The Pepin Heart Institute at AdventHealth Tampa is a facility with a more than 35-year legacy of bringing innovative cardiovascular care to the Tampa Bay area. The Institute was born from personal experience: In 1986, when Tampa resident Art Pepin needed a heart transplant, his only option was more than 500 miles away. After surviving his transplant, he returned home determined to improve access to heart care in his own community. That mission lives on today with his son, Tom Pepin, and granddaughter, Tina, through the Pepin Family Foundation. Together, they carry forward a multigenerational commitment to advancing heart health and expanding access to life-saving treatment. "This procedure is more than a number—it's about lives transformed," Tom Pepin said at a June 4 event celebrating the milestone surgery. "Since becoming the first hospital in Tampa to offer this groundbreaking procedure in 2015, Pepin Heart Institute has been at the forefront of cardiovascular medicine. We're honored to help people in our community live longer, fuller lives." "We're proud to carry on that legacy and ensure world-class, compassionate support is available right here in Tampa Bay," Tina Pepin added. "It's a testament to the power of vision, innovation, and whole-person care." For more than 35 years, the Pepin Heart Institute, in partnership with the Dr. Kiran C. Patel Research Institute, has offered patients early access to breakthrough therapies and technologies in a state-of-the-art, three-story facility dedicated solely to heart care. Learn more at View original content to download multimedia: SOURCE AdventHealth West Florida Division Sign in to access your portfolio
